NEW YORK (GenomeWeb News) – Agilent Technologies said today that “robust growth” in its Bio-Analytical business unit helped drive overall revenue growth of 5 percent for its third fiscal quarter of 2008.
 
For the quarter ended July 31, 2008, Agilent’s total revenues grew to $1.44 billion from $1.37 billion in the comparable period of last year.
 
Bill Sullivan, Agilent’s president and CEO, said in a statement that the company’s total third-quarter revenues “came in at the low end of our expectations.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.